We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 0439K
GlaxoSmithKline PLC
13 April 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) GlaxoSmithKline plc ('GSK') was advised on 13 April 2015 that the following Director and Connected Persons acquired GSK Ordinary Shares ('Shares'), at a price of 1621.10 pence per Share, following the re-investment of the dividend paid to shareholders on 9 April 2015:
Director Ordinary Shares -------------------- ------------------ Sir Andrew Witty 4611 -------------------- ------------------ Connected person Ordinary Shares --------------------------- ------------------ Lady C Witty (Connected person of Sir Andrew Witty) 2223 --------------------------- ------------------ Mr I W Whyte (Connected person of Mrs V A Whyte) 392 --------------------------- ------------------
V A Whyte
Company Secretary
13 April 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSXXLFFEZFZBBB
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions